Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
about
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applicationsDendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issuesToxicological considerations when creating nanoparticle-based drugs and drug delivery systemsAn emerging interface between life science and nanotechnology: present status and prospects of reproductive healthcare aided by nano-biotechnologyDendrimer-coupled sonophoresis-mediated transdermal drug-delivery system for diclofenacEvaluation of poly(amidoamine) dendrimers as potential carriers of iminodiacetic derivatives using solubility studies and 2D-NOESY NMR spectroscopy.Poly(amido amine) dendrimers as absorption enhancers for oral delivery of camptothecin.Advanced Analgesic Drug Delivery and Nanobiotechnology.Transport and biodistribution of dendrimers across human fetal membranes: implications for intravaginal administration of dendrimer-drug conjugates.Structure-skin permeability relationship of dendrimers.Poly(amidoamine) (PAMAM) dendritic nanostructures for controlled site-specific delivery of acidic anti-inflammatory active ingredient.Hyperbranched dendritic nano-carriers for topical delivery of dithranol.Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics.Evaluation of cationic polyamidoamine dendrimers' dermal toxicity in the rat skin modelDegradable polyethylenimine derivate coupled to a bifunctional peptide R13 as a new gene-delivery vectorEffect of size, surface charge, and hydrophobicity of poly(amidoamine) dendrimers on their skin penetrationDendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.Nanostructured materials for applications in drug delivery and tissue engineering.Dendritic systems in drug delivery applications.Tumour and dendrimers: a review on drug delivery aspects.Dendrimers for enhanced drug solubilization.Dendrimeric nanoarchitectures mediated transdermal and oral delivery of bioactivesInnovative pharmaceutical development based on unique properties of nanoscale delivery formulation.Dendrimers as drug delivery vehicles: non-covalent interactions of bioactive compounds with dendrimers.Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Transdermal drug delivery: from micro to nano.Biomaterials as novel penetration enhancers for transdermal and dermal drug delivery systems.Nanoencapsulation for drug deliveryCancer drug delivery in the nano era: An overview and perspectives (Review)Interactions of dendrimers with biological drug targets: reality or mystery - a gap in drug delivery and development research.Dendrimer-based nanocarriers: a versatile platform for drug delivery.Traditional Persian topical medications for gastrointestinal diseases.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesEffect of polyamidoamine (PAMAM) dendrimers on the in vitro release of water-insoluble nifedipine from aqueous gels.Nanoparticles: Emerging carriers for drug delivery.High-Resolution Imaging of Dendrimers Used in Drug Delivery via Scanning Probe Microscopy.Enhancement in deposition and permeation of 5-fluorouracil through human epidermis assisted by peptide dendrimers.In vitro and in vivo evaluation of indomethacin nanoemulsion as a transdermal delivery system.
P2860
Q24599399-BA312656-0B7D-496D-A2E4-03C3BE31EFEEQ26771189-00D403F5-A3E9-40B9-A728-39B444B7E550Q26825175-02C90533-0D71-4976-B4E8-6B139A5CE12CQ28395046-38C03AFA-5D5F-4054-A5F1-EDF97D41026BQ28658189-5E1E9C52-15C3-491C-B5A3-A8258E224E98Q30406066-44948763-42F4-42C6-91DA-431D71898BC0Q30577158-CCE101BB-1E83-42E4-951F-66B44C91132AQ30660775-EE00B6DC-9C26-42F6-A8D3-D66FAE16C9E6Q33845298-ACD59921-5773-4CDA-9247-A142EE85AAEBQ33896898-ABD29989-41F6-463B-9CF9-DDAD7EF21414Q33919858-EAF80F96-2148-4DE7-8A73-2E9FA9FFB1E3Q34476287-BE551E93-3C8A-4DB7-9054-9DAB1C7F2533Q34675249-22407E2D-89EE-4904-BE81-D947CA7002DCQ34827321-FA5FA250-7ADB-437F-ACDE-90FC9B45E8B7Q35171371-5BF3B4E9-3483-4C81-928E-603412E7E748Q35821070-203BDFBF-E65A-4733-ABCD-655C732414BEQ36084040-785D0063-CA3A-42F4-91BF-BE89F0DFACC3Q36690711-66E4A4A8-2153-4FE2-8B25-8A3C3BD38C35Q36807625-6919F7DB-5C52-4630-8135-2854B19574D0Q36945843-28D962DB-9C4E-4D3F-B993-C16D2BDFB5A3Q37171165-E806A9F5-28BA-4290-A2FE-4DEE841A9A0DQ37279284-12FBEFEF-3C04-4E5C-AF15-A0260078EC7FQ37472758-0E0CC475-E4E3-45C0-B164-4C512D5CA1B9Q37602017-1BC65166-F0DF-47E6-B7A0-CA79E8FF82CCQ37644203-CB591EEB-BE82-4F5E-AEE0-BA0450E57A7CQ37823446-790B9283-0FCE-4DD4-9ECA-FAAEBCF33947Q37939967-6E04EB43-1C3A-4D0C-9A08-CBA5BD5257BCQ37984016-FD1D36CC-BC03-4C6B-818C-071DEE87A29DQ38114136-A66B0FD3-0002-42E9-8847-A6017550A44DQ38594967-B9F44058-1610-451C-9A0D-6513F14BCD4AQ38669454-AC5D4B39-7D23-43B2-B223-4FFB98CE6C9DQ38813936-D1B0ACA3-CE7C-417D-AC95-98C34E8E7BB2Q38820422-3CED6F31-4FE6-4DED-99DA-142B5BFD5E0DQ38845246-9E99EB81-B9FF-4280-B7F4-84765F31A7C3Q39339379-4CA95954-F8A8-4F98-8E5F-FAD7EB31CC8AQ41808571-E07E2015-E108-4A18-93EE-81551F79ED85Q42009342-9604E8ED-7D93-4967-B584-FDA9F0AB4246Q42797048-CAC5DB30-7790-4621-9FB2-D88E1A4F2C82Q46347127-8CA1272C-38C0-49DA-8A13-340F42862ADBQ46664350-6457BFB4-4764-4EA0-B545-10415A20334A
P2860
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@ast
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@en
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@nl
type
label
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@ast
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@en
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@nl
prefLabel
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@ast
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@en
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@nl
P2093
P1476
Dendrimer-mediated transdermal delivery: enhanced bioavailability of indomethacin.
@en
P2093
Abhay S Chauhan
Akhlesh K Jain
Kishore B Chalasani
Prakash V Diwan
Sanjay K Jain
P304
P356
10.1016/S0168-3659(03)00200-1
P407
P577
2003-07-01T00:00:00Z